New Search

If you are not happy with the results below please do another search

59 search results for:

1

FFI-Ventures joins Partex.AI

/0 Comments/in ,
FFI-Ventures joins Partex.AI One partner for the drug lifecycle. Precision AI at scale. We are delighted to announce that FFI Ventures is joining Partex.AI, a partnership built on a shared conviction and delivering opportunity for life science companies. Precision AI, combined with deep scientific and commercial expertise, fundamentally changes how therapies develop and reach patients. [...]
2

Seventy voices, one clear signal: AI is no longer optional

/0 Comments/in ,
Reflections from the 3rd AI Forum in Pharma, co-hosted by SHQA and FFI Ventures at the Novartis campus in Rotkreuz in Switzerland, June 11, 2026. Two years ago, the first SHQA-FFI AI Forum asked a simple question: What could AI mean for Pharma? This year, that question has been replaced by something more urgent: How [...]
3

Products Overview

4

oneRay MLR

MLR Precision AI Medical, Legal & Regulatory Review Medical, Legal & Regulatory Review, Reimagined with AI Accelerate Medical, Legal & Regulatory review with AI-powered annotations, Veeva integration, and automated approval workflows. Request a Demo oneRay MLR at a Glance Veeva AI Partner VeevaIntegrated Fully integrated with Veeva RIM, PromoMats & Vault Stand-alone Also available as [...]
5

oneRay Dossier Builder

Dossier Builder AI-Powered Dossier Builder Dossier Builders, Reimagined with AI Accelerate Dossier Builder development with AI-powered evidence compilation, dynamic content assembly, and automated market access documentation across global markets. Request a Demo oneRay Dossier Builder at a Glance 65% Effort reduction, with humans in the lead 70% Shortening of the entire process, reducing time to [...]
6

oneRay SLR

SLR Precision AI Literature Review Systematic Literature Reviews, Reimagined with AI Accelerate evidence synthesis with AI-powered screening, data extraction, and automated reporting across regulatory and medical workflows. Request a Demo oneRay SLR at a Glance 75% Effort reduction while keeping humans in the lead 85% Shortening of the entire process and accelerating drugs to market [...]
7

Human in the Lead: Why the AI Advantage Belongs to Those Who Lead It

/0 Comments/in
AI is rapidly entering life sciences. Research, medical writing, regulatory affairs, market access — few functions are untouched by the conversation. The technology is advancing fast, investment is accelerating, and the pressure to act is real. But speed of adoption and quality of results are not the same thing. And in a highly regulated industry [...]
10

Why Pharma Can’t Afford Good Enough AI

/0 Comments/in
Why Pharma Can't Afford 'Good Enough' AI Generic AI tools like ChatGPT and Microsoft Copilot are rapidly being adopted across pharmaceutical organizations, with teams expecting them to handle complex use cases involving internal medical data. Yet despite their promise, these tools frequently fall short in pharmaceutical, biotech, and medtech environments. While they excel at general [...]